[Comparison of the lowering effect on blood cholesterol of clofibrate and simvastatin]. 1990

M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
Cattedra di III Semeiotica Medica, Università degli Studi di Roma La Sapienza.

The authors report the results obtained in a comparative study of effects of clofibrate and simvastatin. The investigation was carried out on 44 patients with type IIB hypercholesterolemia subdivided into two groups. Throughout the study, patients observed a diet of about 1500 Kcal daily. Thirty days before starting drug treatment, all patients were given a placebo daily, either of the two drugs being administered during the subsequent 30 days. Plasma cholesterol level was examined before starting placebo and before drug treatment and every five days throughout drug treatment. The results obtained showed that both drugs reduced cholesterol plasma level significantly but the reduction obtained with simvastatin was greater than that obtained with clofibrate. The specificity of the use of these drugs in the management of hypercholesterolemia is stressed.

UI MeSH Term Description Entries
D008148 Lovastatin A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. Lovastatin, 1 alpha-Isomer,Mevinolin,6-Methylcompactin,Lovastatin, (1 alpha(S*))-Isomer,MK-803,Mevacor,Monacolin K,1 alpha-Isomer Lovastatin,6 Methylcompactin,Lovastatin, 1 alpha Isomer,MK 803,MK803,alpha-Isomer Lovastatin, 1
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic

Related Publications

M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
November 1978, British journal of pharmacology,
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
August 1977, Atherosclerosis,
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
April 1991, Nederlands tijdschrift voor geneeskunde,
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
July 1981, Atherosclerosis,
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
July 1997, Lancet (London, England),
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
May 2005, Archives of internal medicine,
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
March 1995, Lancet (London, England),
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
November 1961, Arztliche Forschung,
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
January 1990, Drug metabolism and disposition: the biological fate of chemicals,
M S Gavelli, and E Vitaliano, and T Serra, and F G Rossi, and A Rizzuti, and R Caridis, and J Tozzi
August 1963, Iryo,
Copied contents to your clipboard!